Cargando…
Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
BACKGROUND: Translocations are hallmarks of non-Hodgkin lymphoma (NHL) genomes. Because lymphoid cell development processes require the creation and repair of double stranded breaks, it is not surprising that disruption of this type of DNA repair can cause cancer. The members of the MRE11-RAD50-NBS1...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788526/ https://www.ncbi.nlm.nih.gov/pubmed/19917125 http://dx.doi.org/10.1186/1471-2350-10-117 |
_version_ | 1782174987798446080 |
---|---|
author | Schuetz, Johanna M MacArthur, Amy C Leach, Stephen Lai, Agnes S Gallagher, Richard P Connors, Joseph M Gascoyne, Randy D Spinelli, John J Brooks-Wilson, Angela R |
author_facet | Schuetz, Johanna M MacArthur, Amy C Leach, Stephen Lai, Agnes S Gallagher, Richard P Connors, Joseph M Gascoyne, Randy D Spinelli, John J Brooks-Wilson, Angela R |
author_sort | Schuetz, Johanna M |
collection | PubMed |
description | BACKGROUND: Translocations are hallmarks of non-Hodgkin lymphoma (NHL) genomes. Because lymphoid cell development processes require the creation and repair of double stranded breaks, it is not surprising that disruption of this type of DNA repair can cause cancer. The members of the MRE11-RAD50-NBS1 (MRN) complex and BLM have central roles in maintenance of DNA integrity. Severe mutations in any of these genes cause genetic disorders, some of which are characterized by increased risk of lymphoma. METHODS: We surveyed the genetic variation in these genes in constitutional DNA of NHL patients by means of gene re-sequencing, then conducted genetic association tests for susceptibility to NHL in a population-based collection of 797 NHL cases and 793 controls. RESULTS: 114 SNPs were discovered in our sequenced samples, 61% of which were novel and not previously reported in dbSNP. Although four variants, two in RAD50 and two in NBS1, showed association results suggestive of an effect on NHL, they were not significant after correction for multiple tests. CONCLUSION: These results suggest an influence of RAD50 and NBS1 on susceptibility to diffuse large B-cell lymphoma and marginal zone lymphoma. Larger association and functional studies could confirm such a role. |
format | Text |
id | pubmed-2788526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27885262009-12-04 Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma Schuetz, Johanna M MacArthur, Amy C Leach, Stephen Lai, Agnes S Gallagher, Richard P Connors, Joseph M Gascoyne, Randy D Spinelli, John J Brooks-Wilson, Angela R BMC Med Genet Research article BACKGROUND: Translocations are hallmarks of non-Hodgkin lymphoma (NHL) genomes. Because lymphoid cell development processes require the creation and repair of double stranded breaks, it is not surprising that disruption of this type of DNA repair can cause cancer. The members of the MRE11-RAD50-NBS1 (MRN) complex and BLM have central roles in maintenance of DNA integrity. Severe mutations in any of these genes cause genetic disorders, some of which are characterized by increased risk of lymphoma. METHODS: We surveyed the genetic variation in these genes in constitutional DNA of NHL patients by means of gene re-sequencing, then conducted genetic association tests for susceptibility to NHL in a population-based collection of 797 NHL cases and 793 controls. RESULTS: 114 SNPs were discovered in our sequenced samples, 61% of which were novel and not previously reported in dbSNP. Although four variants, two in RAD50 and two in NBS1, showed association results suggestive of an effect on NHL, they were not significant after correction for multiple tests. CONCLUSION: These results suggest an influence of RAD50 and NBS1 on susceptibility to diffuse large B-cell lymphoma and marginal zone lymphoma. Larger association and functional studies could confirm such a role. BioMed Central 2009-11-16 /pmc/articles/PMC2788526/ /pubmed/19917125 http://dx.doi.org/10.1186/1471-2350-10-117 Text en Copyright ©2009 Schuetz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research article Schuetz, Johanna M MacArthur, Amy C Leach, Stephen Lai, Agnes S Gallagher, Richard P Connors, Joseph M Gascoyne, Randy D Spinelli, John J Brooks-Wilson, Angela R Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma |
title | Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma |
title_full | Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma |
title_fullStr | Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma |
title_full_unstemmed | Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma |
title_short | Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma |
title_sort | genetic variation in the nbs1, mre11, rad50 and blm genes and susceptibility to non-hodgkin lymphoma |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788526/ https://www.ncbi.nlm.nih.gov/pubmed/19917125 http://dx.doi.org/10.1186/1471-2350-10-117 |
work_keys_str_mv | AT schuetzjohannam geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT macarthuramyc geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT leachstephen geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT laiagness geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT gallagherrichardp geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT connorsjosephm geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT gascoynerandyd geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT spinellijohnj geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma AT brookswilsonangelar geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma |